These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 25651904)
21. Oestrogens and progestins and breast cancer risk in post-menopausal women. La Vecchia C Pharmacol Res; 1995 Dec; 32(6):323-4. PubMed ID: 8736479 [No Abstract] [Full Text] [Related]
22. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution. Chlebowski RT; Prentice RL J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547 [No Abstract] [Full Text] [Related]
23. Hormone replacement therapy and the menopause. Australian Menopause Society. MacLennan AH Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437 [No Abstract] [Full Text] [Related]
24. [Hormone replacement therapy of menopause in women with vascular risk factors]. Charbonnel B Diabete Metab; 1993; 19(4):387-90. PubMed ID: 8293865 [No Abstract] [Full Text] [Related]
26. Estrogen-progestin replacement and risk of breast cancer. Harvey JA JAMA; 2000 Aug; 284(6):692; author reply 693-4. PubMed ID: 10927768 [No Abstract] [Full Text] [Related]
27. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Archer DF; Bush T; Nachtigall LE J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695 [No Abstract] [Full Text] [Related]
28. The history of hormone therapy use and recent controversy related to heart disease and breast cancer arising from prevention trial outcomes. Alexander IM J Midwifery Womens Health; 2012; 57(6):547-557. PubMed ID: 23217066 [TBL] [Abstract][Full Text] [Related]
30. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial. Shapiro S Climacteric; 2003 Dec; 6(4):302-10; discussion 310-3. PubMed ID: 15006251 [TBL] [Abstract][Full Text] [Related]
31. Estrogen and progestogen therapy in postmenopausal women. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850 [No Abstract] [Full Text] [Related]
32. Hormone replacement and breast cancer. A remaining controversy? Adami HO; Persson I JAMA; 1995 Jul; 274(2):178-9. PubMed ID: 7596008 [No Abstract] [Full Text] [Related]
33. Postmenopausal estrogens--opposed, unopposed, or none of the above. Willett WC; Colditz G; Stampfer M JAMA; 2000 Jan; 283(4):534-5. PubMed ID: 10659883 [No Abstract] [Full Text] [Related]
34. Breast cancer: the role of hormone therapy. Creasman WT Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202 [TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251 [TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study. Nozaki M; Koera K; Nagata H; Nakano H J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106 [TBL] [Abstract][Full Text] [Related]
37. Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada. Kirsh V; Kreiger N Cancer Causes Control; 2002 Aug; 13(6):583-90. PubMed ID: 12195648 [TBL] [Abstract][Full Text] [Related]
38. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related]
39. Estrogen-progestin replacement and risk of breast cancer. Roca CA; Schmidt PJ; Daly RC; Rubinow DR JAMA; 2000 Aug; 284(6):693-4. PubMed ID: 10927770 [No Abstract] [Full Text] [Related]
40. Estrogen-progestin replacement and risk of breast cancer. Glaser AN JAMA; 2000 Aug; 284(6):692; author reply 693-4. PubMed ID: 10927767 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]